FLT3 inhibitors have been shown to induce cytotoxic effects and suppress the growth of primary leukemic blasts from patients with FLT3-ITD+ AML and BA/F3 cells expressing constitutively active FLT3 [13–15]. Here, FLT3 is linked to acute myeloid leukemia.